Maribel Salas

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 30

Top Topics

Acute Myeloid Leukemia

Prognostic Factors

Top Venues

Future oncology (London, England)

Biomarkers in medicine

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jyoti D Patel, Jie Meng, Hoa Le, Yoko Tanaka, Sudarshan Phani, Maribel Salas, Chuntao Wu, David Sternberg, Stephen Esker, Jeffrey P Anderson, Aaron Crowley, Summera Q Zhou, Camryn Lieb, Haiyan Sun, Quan V Doan, Anu Santhanagopal, Karen L Reckamp
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy. Advances in therapy 41 (8) (2024)
Charles Dharmani, Oluwatosin Fofah, Maura Fallon, Abdul Waheed Rajper, Margaret Wooddell, Maribel Salas
TURALIO ® Risk Evaluation and Mitigation Strategy Program (tREMS): 3-year retrospective hepatic safety assessment. Future oncology (London, England) (2024)
Eric Wang, Mackenzie Henderson, Priyanka Yalamanchili, Jenilee Cueto, Zahidul Islam, Charles Dharmani, Maribel Salas
Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework. Biomarkers in medicine 18 (6) (2024)
Charles Dharmani, Oluwatosin Fofah, Eric Wang, Maribel Salas, Margaret Wooddell, Nora Tu, Jenny Tse, Aimee M Near, Gabriel Tinoco
Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA. Future oncology (London, England) (2024)
Jyoti D Patel, Jie Meng, Hoa Le, Yoko Tanaka, Sudarshan Phani, Maribel Salas, Chuntao Wu, David Sternberg, Stephen Esker, Jeffrey P Anderson, Aaron Crowley, Summera Q Zhou, Camryn Lieb, Haiyan Sun, Quan V Doan, Anu Santhanagopal, Karen L Reckamp
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy. Advances in therapy 41 (8) (2024)
Eric Wang, Mackenzie Henderson, Priyanka Yalamanchili, Jenilee Cueto, Zahidul Islam, Charles Dharmani, Maribel Salas
Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework. Biomarkers in medicine 18 (6) (2024)
Eric Wang, Mackenzie Henderson, Priyanka Yalamanchili, Jenilee Cueto, Zahidul Islam, Charles Dharmani, Maribel Salas
Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework. Biomarkers in medicine (2024)
Charles Dharmani, Oluwatosin Fofah, Eric Wang, Maribel Salas, Margaret Wooddell, Nora Tu, Jenny Tse, Aimee M Near, Gabriel Tinoco
Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA. Future oncology (London, England) (2024)
Jyoti D Patel, Jie Meng, Hoa Le, Yoko Tanaka, Sudarshan Phani, Maribel Salas, Chuntao Wu, David Sternberg, Stephen Esker, Jeffrey P Anderson, Aaron Crowley, Summera Q Zhou, Camryn Lieb, Haiyan Sun, Quan V Doan, Anu Santhanagopal, Karen L Reckamp
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy. Advances in therapy 41 (8) (2024)
Charles Dharmani, Oluwatosin Fofah, Eric Wang, Maribel Salas, Margaret Wooddell, Nora Tu, Jenny Tse, Aimee M Near, Gabriel Tinoco
Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA. Future oncology (London, England) 20 (16) (2024)
Charles Dharmani, Oluwatosin Fofah, Eric Wang, Maribel Salas, Margaret Wooddell, Nora Tu, Jenny Tse, Aimee M Near, Gabriel Tinoco
Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA. Future oncology (London, England) 20 (16) (2024)
Eric Wang, Mackenzie Henderson, Priyanka Yalamanchili, Jenilee Cueto, Zahidul Islam, Charles Dharmani, Maribel Salas
Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework. Biomarkers in medicine 18 (6) (2024)
Jyoti D Patel, Jie Meng, Hoa Le, Yoko Tanaka, Sudarshan Phani, Maribel Salas, Chuntao Wu, David Sternberg, Stephen Esker, Jeffrey P Anderson, Aaron Crowley, Summera Q Zhou, Camryn Lieb, Haiyan Sun, Quan V Doan, Anu Santhanagopal, Karen L Reckamp
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy. Advances in therapy (2024)
Charles Dharmani, Sudhir Unni, Ngan Pham, Nazneen Fatima Shaikh, Yan Xiong, Rohan Vashi, Oluwatosin Fofah, Alessandria Strubing, Maribel Salas, Nora Tu, Margaret Wooddell, Xiaoyu Zhou, Aimee M Near
Real-world treatment patterns, healthcare resource utilization and costs among patients with peripheral T-cell lymphoma. Future oncology (London, England) (2023)
Maribel Salas, Maxine Gossell-Williams, Priyanka Yalamanchili, Sameer Dhingra, Marina A Malikova, Omar Aimer, Toluwalope Junaid
The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature. Biomarker insights 18 (2023)
Charles Dharmani, Eric Wang, Nora Tu, Oluwatosin Fofah, Jenilee Cueto, Maribel Salas, Yasser Mostafa Kamel
Elderly patients with acute myeloid leukemia who only receive supportive care in the Surveillance, Epidemiology and End Results-Medicare database: demographics, treatment patterns and outcomes. Future oncology (London, England) (2023)
Blanca Boluda, Antonio Solana-Altabella, Isabel Cano, David Martínez-Cuadrón, Evelyn Acuña-Cruz, Laura Torres-Miñana, Rebeca Rodríguez-Veiga, Irene Navarro-Vicente, David Martínez-Campuzano, Raquel García-Ruiz, Pilar Lloret, Pedro Asensi, Ana Osa-Sáez, Jaume Aguero, María Rodríguez-Serrano, Francisco Buendía-Fuentes, Juan Eduardo Megías-Vericat, Beatriz Martín-Herreros, Eva Barragán, Claudia Sargas, Maribel Salas, Margaret Wooddell, Charles Dharmani, Miguel Angel Sanz, Javier de la Rubia, Pau Montesinos
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia. Cancers 15 (8) (2023)
Charles Dharmani, Eric Wang, Nora Tu, Maribel Salas, Yasser Mostafa Kamel
Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the Surveillance, Epidemiology and End Results-Medicare database. Future oncology (London, England) (2023)
Blanca Boluda, Antonio Solana-Altabella, Isabel Cano, David Martínez-Cuadrón, Evelyn Acuña-Cruz, Laura Torres-Miñana, Rebeca Rodríguez-Veiga, Irene Navarro-Vicente, David Martínez-Campuzano, Raquel García-Ruiz, Pilar Lloret, Pedro Asensi, Ana Osa-Sáez, Jaume Aguero, María Rodríguez-Serrano, Francisco Buendía-Fuentes, Juan Eduardo Megías-Vericat, Beatriz Martín-Herreros, Eva Barragán, Claudia Sargas, Maribel Salas, Margaret Wooddell, Charles Dharmani, Miguel Angel Sanz, Javier de la Rubia, Pau Montesinos
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia. Cancers 15 (8) (2023)
Luciane Cruz Lopes, Maribel Salas, Claudia Garcia Serpa Osorio-de-Castro, Lisiane Freitas Leal, Svetlana V Doubova, Martín Cañás, Anahí Cristina Dreser-Mansilla, Angela Acosta, André de Oliveira Baldoni, Cristiane de Cássia Bergamaschi, Daniel Marques Mota, Diana-Lizbeth Gómez-Galicia, Dino Sepúlveda-Viveros, Edgard Narvaez Delgado, Elisangela da Costa Lima, Felipe Daniel Vera, Felipe Ferre, Gustavo H Marín, Ismael Olmos, Ivan Ricardo Zimmermann, Izabela Fulone, Juan Roldán-Saelzer, Juan Carlos Sánchez-Salgado, Lucila Isabel Castro-Pastrana, Luiz Jupiter Carneiro de Souza, Manuel Machado Beltrán, Marcus Tolentino Silva, María Belén Mena, Marta Maria de França Fonteles, Martín Alejandro Urtasun, Mónica Tarapués, Patricia Granja Hernández, Natalia Medero, Raquel Herrera-Comoglio, Silvio Barberato-Filho, Marcus Tolentino Silva, Vera Lúcia Luiza, Yared Santa-Ana, L Yesenia Rodríguez-Tanta, Monique Elseviers
Data sources for drug utilization research in Latin American countries-A cross-national study: DASDUR-LATAM study. Pharmacoepidemiology and drug safety 31 (3) (2022)
Maribel Salas, Jan Petracek, Priyanka Yalamanchili, Omar Aimer, Dinesh Kasthuril, Sameer Dhingra, Toluwalope Junaid, Tina Bostic
The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature. Pharmaceutical medicine 36 (5) (2022)
Maribel Salas, Margaret Mordin, Margaret Mordin, Zahidul Islam, Nora Tu, Michelle D Hackshaw
Health-related quality of life in women with breast cancer: a review of measures. BMC cancer 22 (1) (2022)
Charles Dharmani, Eric Wang, Maribel Salas, Colleen McCabe, Alvileen Diggs, Youngsook Choi, Jason Jiang, Vicki L Keedy
Turalio risk evaluation and mitigation strategy for treatment of tenosynovial giant cell tumor: framework and experience. Future oncology (London, England) 18 (13) (2022)
Michelle D Hackshaw, Heather E Danysh, Mackenzie Henderson, Eric Wang, Nora Tu, Zahidul Islam, Amy Ladner, Mary E Ritchey, Maribel Salas
Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review. BMC cancer 21 (1) (2021)
Maxine Gossell-Williams, Veronique F Kugener, Maribel Salas, Kenneth I Maynard, Abimbola Cole
An Update of the North American Chapter of the International Society of Pharmacovigilance (NASoP). Drug safety 44 (5) (2021)
Maribel Salas, Michele Julian, Youngsook Choi, Zahid Islam, Mackenzie Henderson, Annette Stemhagen, Natalie O'Donnell, Nora Tu
Evaluation of patient/caregiver and healthcare provider knowledge, attitudes and behavior for safety and use of pexidartinib. Journal of comparative effectiveness research 10 (12) (2021)
Veronique F Kugener, Eric S Freedland, Kenneth I Maynard, Omar Aimer, Peggy S Webster, Maribel Salas, Maxine Gossell-Williams
Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities. Drug safety 44 (8) (2021)
Maribel Salas, Michele Julian, Leonidas Drogaris, Zahidul Islam, Mackenzie Henderson, Annette Stemhagen, Natalie O'Donnell, Nora Tu
A qualitative evaluation of patient and healthcare provider knowledge, attitudes, and behavior for safety and use of pexidartinib. Journal of comparative effectiveness research 10 (3) (2021)
Kathryn Duensing, Robert Twillman, Stephen Ziegler, M Soledad Cepeda, David M Kern, Maribel Salas, Gregory Wedin
An Examination of State and Federal Opioid Analgesic and Continuing Education Policies: 2016-2018. Journal of pain research 13 (2020)
Maribel Salas, Luciane C Lopes, Brian B Godman, Ilse Truter, Abraham G Hartzema, Bjorn Wettermark, Joseph Olusesan Fadare, Johanita Riétte Burger, Kwame Appenteng, Macarius Donneyong, Ariel Arias, Daniel Ankrah, Olanyika O Ogunleye, Martha Lubbe, Laura Horne, Jorgelina Bernet, Diana L Gómez-Galicia, Miriam Del Carmen Garcia Estrada, Margaret N Oluka, Amos Massele, Luis Alesso, Raquel Herrera-Comoglio, Elisangela da Costa Lima, Carmen Vilaseca, Ulf Bergman
Challenges facing drug utilization research in the Latin American region. Pharmacoepidemiology and drug safety 29 (11) (2020)